Work Files Saved Searches
   My Account                                                  Search:   Quick/Number   Boolean   Advanced   Derwent    Help   


 The Delphion Integrated View

  Buy Now:   Buy PDF- 18pp  PDF  |   File History  |   Other choices   
  Tools:  Citation Link  |  Add to Work File:    
  View:  Expand Details   |  INPADOC   |  Jump to: 
  Go to:  Derwent  
 Email this to a friend  Email this to a friend 
       
Title: US5817689: Indole derivatives having a 2-phenyl-ethanolamino-substituted lower alkyl group at the 2-or 3-position thereof
[ Derwent Title ]


Country: US United States of America

View Images High
Resolution

 Low
 Resolution

 
18 pages

 
Inventor: Kato, Shiro; Sakai, Japan
Harada, Hiroshi; Suita, Japan
Hirokawa, Yoshimi; Ikoma, Japan
Yoshida, Naoyuki; Sakai, Japan
Kawashima, Hitoshi; Osaka, Japan

Assignee: Dainippon Pharmaceutical Co., Ltd., Osaka, Japan
other patents from DAINIPPON PHARMACEUTICAL CO. LTD. (133415) (approx. 145)
 News, Profiles, Stocks and More about this company

Published / Filed: 1998-10-06 / 1997-05-29

Application Number: US1997000836983

IPC Code: Advanced: A61K 31/40; A61K 31/404; C07D 209/14; C07D 209/24; C07D 209/30;
Core: A61K 31/403; C07D 209/00; more...
IPC-7: A61K 31/40; C07D 209/14;

ECLA Code: C07D209/14; M07D209/14;

U.S. Class: Current: 514/415; 514/411; 514/866; 514/909; 548/431; 548/506;
Original: 514/415; 514/411; 514/866; 514/909; 548/431; 548/506;

Field of Search: 548/506,431 514/411,415

Priority Number:
1994-11-29  JP1994000321402

Abstract:     PCT No. PCT/JP95/02400 Sec. 371 Date May 29, 1997 Sec. 102(e) Date May 29, 1997 PCT Filed Nov. 27, 1995 PCT Pub. No. WO96/16938 PCT Pub. Date Jun. 6, 1996An indole derivative of the formula: <IMAGE>l-lower alkoxy, carboxy-lower alkoxy, lower alkoxycarbonyl, phenyl-lower alkoxy, lower alkyl being optionally substituted by hydroxy, di-lower alkylaminosulfonyl, etc., R2 is hydrogen, halogen, lower alkoxy, lower alkoxycarbonyl-lower alkoxy, carboxy-lower alkoxy, etc., R3 is hydrogen or lower alkyl, R4 is halogen or trifluoromethyl, R5 is lower alkyl, or a salt thereof, these compounds being potent beta 3-adrenergic receptor-stimulating agent with excellent adrenoceptor selectivity, and being useful in the prophylaxis or treatment of obesity or diabetes mellitus.

Attorney, Agent or Firm: Foley & Lardner ;

Primary / Asst. Examiners: McKane, Joseph; Stockton, Laura L.

INPADOC Legal Status: Show legal status actions          Buy Now: Family Legal Status Report

Designated Country: AL AM AP BB BG BY EE GE IS KG KR KZ LK LR LT LV  AT BE CH DE DK ES FR GB GR IE IT LI LU MC 

Family: Show 43 known family members

First Claim:
Show all 25 claims
We claim:     1. An indole derivative of the formula [I]: [Figure] wherein R1 is a lower alkyl group being optionally substituted by a hydroxy group, a phenylsulfonylamino group, a lower alkylsulfonylamino group, a mono- or di-lower alkylaminosulfonyl group, or a group selected from the following (a) to (d), or combines with R2 to form a methylenedioxy group, said methylenedioxy group being optionally substituted by a carboxyl group or a lower alkoxycarbonyl group,
  • (a) a group of the formula:--X--Ra (wherein X is O, S or NH, Ra is a hydrogen atom or a lower alkyl group, provided that when X is S, then Ra is a lower alkyl group);
  • (b) a group of the formula: [Figure] Rb (wherein Rb is a hydrogen atom, a lower alkyl group, a lower alkoxycarbonyl group or a carboxyl group, Rbb is a lower alkoxycarbonyl group or a carboxyl group, m is an integer of 0 to 3, and n is 0 or 1);
  • (c) a group of the formula:--O(CH2)p --Rc (wherein Rc is a lower alkanoyl group, a hydroxy group, a cyano group, a phenyl group, a mono- or di-lower alkylaminocarbonyl group, or a group of the formula: [Figure] (wherein RA is a hydrogen atom or a lower alkyl group), and p is an integer of 1 to 4); and
  • (d) a group of the formula:--Y--(CH2)q --Rd (wherein Y is NH or S, Rd is a carboxyl group or a lower alkoxycarbonyl group, and q is an integer of 1 to 4);
  • R2 is a hydrogen atom, a halogen atom, a lower alkyl group being optionally substituted by a hydroxy group, a hydroxy group, a lower alkoxy group, or a group of the above (b) or (c), or combines with R1 to form a methylenedioxy group, said methylenedioxy group being optionally substituted by a carboxyl group or a lower alkoxycarbonyl group;
  • R3 is a hydrogen atom or a lower alkyl group;
  • W is a group of the formula [II] which bonds to the 2- or 3-position of the indole nucleus: [Figure] wherein R4 is a halogen atom or a trifluoromethyl group, and R5 is a lower alkyl group, or a salt thereof.


Background / Summary: Show background / summary

Drawing Descriptions: Show drawing descriptions

Description: Show description

PCT Number: PCT/JP95/02400    WO9616938

PCT Pub./Filed Dates: 1996-06-06 / 1995-11-27

§ 371 / 102(e) Dates: 1997-05-29 / 1997-05-29

Forward References: Show 4 U.S. patent(s) that reference this one

       
U.S. References: Go to Result Set: All U.S. references   |  Forward references (4)   |   Backward references (1)   |   Citation Link

Buy
PDF
Patent  Pub.Date  Inventor Assignee   Title
Buy PDF- 7pp US4055658  1977-10 Kreighbaum et al.  Mead Johnson & Company Cyanomethylphenethanolamines
       
Foreign References:
Buy
PDF
Publication Date IPC Code Assignee   Title
  JP06345731 1994-12       
Buy PDF GB0861428 1959-07  C07D 209/00 SEARLE & CO Improvements in or relating to indole derivatives 
Buy PDF- 17pp GB2135883 1984-09  C07D 209/00 BRISTOL MYERS CO Anti-inflammatory B2 agonists 


Other Abstract Info: CHEMABS 125(11)142550C DERABS C96-277685

Other References:
  • Bobzin et al., "Aromatic Alkaloids from the Marine Sponge Chelonaplysilla", J. Org. Chem., 56, 4403-4407 (1991). (5 pages) Cited by 5 patents [ISI abstract]
  • Chemical Abstract, 78, 431, 71665s (1973).
  • Clifton et al., "Arylethanolamines Derived from Salicylamide with α-and β-Adrenoceptor Blocking Activities. Preparation of Lebetalol, Its Enantiomers, and Related Salicylamides", 25, 670-679 (1982). (10 pages) Cited by 19 patents
  • Jackman et al., "Some tryptamine derivatives: 1-aryloxy-3-[(2-indol-3'-ylethyl)amino]propan-2-ols", J. Pharm. Pharmacol., 17, 742-746 (1965).
  • Chemical Abstract, 96, 726, 142543k (1982).
  • Chemical Abstract, 109, 666, 128763n (1988).
  • Kato et al., CA 122:239540, May 8, 1995.
  • Patent Abstracts of Japan for JP 06345731, 1994.


  • Inquire Regarding Licensing

    Powered by Verity


    Plaques from Patent Awards      Gallery of Obscure PatentsNominate this for the Gallery...

    Thomson Reuters Copyright © 1997-2010 Thomson Reuters 
    Subscriptions  |  Web Seminars  |  Privacy  |  Terms & Conditions  |  Site Map  |  Contact Us  |  Help